
Integer Holdings (ITGR) Stock Forecast & Price Target
Integer Holdings (ITGR) Analyst Ratings
Bulls say
Integer Holdings Corp demonstrates a positive outlook due to significant revenue growth in key segments, particularly a 15% increase in the Cardio & Vascular segment in the third quarter of 2025. The company is expected to continue this trend with new product launches scheduled for late 2026 and 2027, aiming for at least mid-single-digit top-line growth and steady gross margins projected at approximately 27% for the next two years. Additionally, the forecast for operating cash flow reflects a healthy increase to $230-$240 million in 2025, contributing to improved leverage ratios and positioning the company favorably within the resilient cardiovascular device market.
Bears say
Integer Holdings Corp has adjusted its revenue estimates for 4Q25E to $460.0 million, representing only a 2% increase from the prior year, which is a downward revision from previous expectations of $477.0 million. Furthermore, the company has lowered its full-year 2025 revenue guidance by $16 million and provided a flat-to-lower outlook for 2026E due to weaker-than-anticipated demand for three specific products, indicating potential ongoing challenges in growth. This situation has led to a projected decline in adjusted operating income of approximately 1.5% and raises concern about the company’s ability to recover from slower market adoption of its key products in the near term.
This aggregate rating is based on analysts' research of Integer Holdings and is not a guaranteed prediction by Public.com or investment advice.
Integer Holdings (ITGR) Analyst Forecast & Price Prediction
Start investing in Integer Holdings (ITGR)
Order type
Buy in
Order amount
Est. shares
0 shares